Cancer marker profile-Ovarian-Comprehensive
Sample Type
Recommended for
Report
Ovary is the female reproductive organ mainly responsible for the production of female hormones and has a major role in fertility and sexual functions. Ovarian disorders can often lead to hormonal imbalance and fertility issues. Ovarian cancers or malignancies occur due to formation of abnormal multiplication of cells or tissues leading to the formation of fibroids or mass which can often be cancerous. The diagnosis or initial screening is done by certain cancer marker and some hormonal tests. Cancer markers or tumour markers are proteins produced by the normal cells as well as cancer cells, but are produced in higher levels by the cancer cells. Cancer marker profile- Ovarian-Comprehensive consists of tests to measure the levels of tumour markers in the blood, urine, and other body fluids. This profile test is used along with other tests may be helpful in the diagnosis of ovarian cancer and decide the treatment prognosis. This test should however, not be used in isolation for the diagnosis of ovarian tumours.
Price : ₹ 2,385
The Cancer marker profile Ovarian-Comprehensive measures the CA125, CEA, AFP, HCG, LDH levels in the blood.
- The test along with other specialized tests is used for the initial screening of ovarian cancer cases.
- The profile tests can be used for monitoring treatment and relapse in patients with ovarian, uterine or even breast cancers.
- The test may be used as a prognostic marker for survival following cancer surgeries or any ovarian or uterine surgeries.
- To know the stage of cancer as well as the metastasis status
- The test can help detect recurrence, metastasis and residual cancer: This may even include patients with a history of cancer of other organs like breast, lung, pancreas etc.
Ovarian cancer may initially present as:
- Abdominal pain with bloating
- Menstrual irregularities
- Weight fluctuations.
- Pelvic pain at times accompanied with back pain.
- Reproductive issues.
Certain high risk patients may also require testing:
- Patients already undergoing treatment for cancer.
- Patients who have completed the treatment to know the disease status.
- Familial history of cancers.
- Patients with inherited genetic components
- Patients with endometriosis (painful disorder of the lining of the uterus)
- Post hormone replacement therapies
- Early menopause patients.
This test requires a blood sample. A tourniquet (elastic) band is placed tightly on the upper arm. The patient is then asked to make a fist. This helps in the build-up of blood filling the veins. The skin is disinfected before needle insertion and the blood sample is collected in vacutainer.
- CEA test
- CA 125 test
- AFP test
- HCG test
- LDH test
